| __timestamp | Bristol-Myers Squibb Company | Johnson & Johnson |
|---|---|---|
| Wednesday, January 1, 2014 | 4534000000 | 8494000000 |
| Thursday, January 1, 2015 | 5920000000 | 9046000000 |
| Friday, January 1, 2016 | 4940000000 | 9095000000 |
| Sunday, January 1, 2017 | 6411000000 | 10554000000 |
| Monday, January 1, 2018 | 6345000000 | 10775000000 |
| Tuesday, January 1, 2019 | 6148000000 | 11355000000 |
| Wednesday, January 1, 2020 | 11143000000 | 12340000000 |
| Friday, January 1, 2021 | 10195000000 | 14277000000 |
| Saturday, January 1, 2022 | 9509000000 | 14135000000 |
| Sunday, January 1, 2023 | 9299000000 | 15048000000 |
| Monday, January 1, 2024 | 11159000000 | 17232000000 |
Unleashing insights
In the competitive world of pharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Johnson & Johnson and Bristol-Myers Squibb Company have been at the forefront of this race. From 2014 to 2023, Johnson & Johnson consistently outpaced Bristol-Myers Squibb in R&D spending, with an average annual expenditure of approximately 11.5 billion dollars, compared to Bristol-Myers Squibb's 7.4 billion dollars.
In 2020, both companies reached their peak R&D investments, with Johnson & Johnson spending 12.3 billion dollars and Bristol-Myers Squibb hitting 11.1 billion dollars. This surge underscores their commitment to pioneering new treatments and therapies. By 2023, Johnson & Johnson's R&D spending had increased by 77% from 2014, while Bristol-Myers Squibb saw a 105% rise. These figures highlight the relentless pursuit of innovation in the pharmaceutical industry.
Operational Costs Compared: SG&A Analysis of Johnson & Johnson and Bristol-Myers Squibb Company
Who Prioritizes Innovation? R&D Spending Compared for Johnson & Johnson and Biogen Inc.
Johnson & Johnson or Arrowhead Pharmaceuticals, Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Amgen Inc. and Bristol-Myers Squibb Company
Bristol-Myers Squibb Company vs Gilead Sciences, Inc.: Strategic Focus on R&D Spending
R&D Insights: How Bristol-Myers Squibb Company and Zoetis Inc. Allocate Funds
Bristol-Myers Squibb Company or BeiGene, Ltd.: Who Invests More in Innovation?
Comparing Innovation Spending: Bristol-Myers Squibb Company and Dr. Reddy's Laboratories Limited
Research and Development: Comparing Key Metrics for Bristol-Myers Squibb Company and Alkermes plc
Comparing Innovation Spending: Bristol-Myers Squibb Company and PTC Therapeutics, Inc.
Comparing Innovation Spending: Bristol-Myers Squibb Company and Catalyst Pharmaceuticals, Inc.
Bristol-Myers Squibb Company vs Perrigo Company plc: Strategic Focus on R&D Spending